Twitter Beğeni Hilesi

Fantastic hospitality and very impressed with the ASCO representation in Japan

Such a lovely trip to Japan and so glad to meet new friends. JSMO and ASCO joint symposium, CAR T and bispecifics. JSMOs 20th anniversary. Such a great experience. Jessica Hawley MD MS did a great talk on CAR T/bispecific in prostate ca

Want a nice trip to Berlin with some education to match, join us!

Love my lymphoma family. Glad I was able to witness the friendship of Andrew M. Evens, DO, MBA, MSc and Soni Smith MD and thankful to be part of the Ultmann legacy #IUCLS2023.

This was great fun, learned a lot about bispecifics in DLBCL. Take a listen!

I was inspired by the next wave of investigators in lymphoma and CLL, the future is bright!

One of my favorite engagements this year. The future is bright for oncology patients. Outstanding group of young investigators!

Outstanding job by the cooperative groups, newly a quarter of the study population was Hispanic or AA, it can be done

Dr. Christopher Lathan from DFCI addressing health inequity particularly as it pertains to technological advances that widen the gap. Excellent talk and kudos to ASCO for providing the platform

So happy to see all the fantastic accomplishments of our esteemed colleagues in leukemia, keep inspiring me to do more!

Such an amazing group of mentors

Impressive job by my colleague Ranjit Nair presenting phase 1 study results of TNB-486 in R/R FL. Early efficacy looks very promising

Important, multi-disciplinary, joint pediatric/adult leukemia group effort led by our Drs Branko Cuglievan & Naveen Pemmaraju, MD → highlighting new era of research & discovery for #BPDCN in #pediatric and #AYA patients doi.org/10.1038/s41375… Leukemia Journal MD Anderson Cancer Center

Such a privilege to know Soni Smith MD who has over the way for women in academia. No better example of someone who has navigated all the challenges beautifully and is the example for many. Women In Lymphoma - [email protected]

Such a great time. One of my favorite new memories

Such a fun evening, thanks for letting me tag along!

Super excited and thankful that we reached this major milestone. This phase 2 study met its primary endpoint! mosun+pola: outpatient administration, fixed duration, durable remission with 2 year follow up; median PFS 11.4 months.

Excited for patients with FL to have a new option- lisp-cel CAR T. Grateful to our patients and study staff. Proud to have been part of this important trial rdcu.be/dJXy9

Bittersweet day, celebrated my phenomenal research team. I tell my girls, surround yourself by those that are better than you so that you will grow. I am surrounded by the very best.

So proud of these two fellows, they are truly exceptional Neha Akkad and Dustin McCurry Dustin McCurry